Filing Details
- Accession Number:
- 0001610717-23-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-15 16:37:41
- Reporting Period:
- 2023-05-11
- Accepted Time:
- 2023-05-15 16:37:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1421050 | Mathai Mammen | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2023-05-11 | 200,000 | $1.16 | 202,745 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2023-05-11 | 33,000 | $52.82 | 169,745 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-05-11 | 200,000 | $0.00 | 200,000 | $1.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-06-12 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- All of the shares subject to the option are fully vested and exercisable as of the date hereof.